The MLL5 gene, also known as the lysine N-methyltransferase 2 gene, was initially identified as a candidate tumor suppressor gene consisting of 25 coding exons translated into a protein of 1,858 amino acid residues (32). The gene discussed is KMT2E; the disease is neoplasm.